Search research articles
Contact Us
Filters
Showing results (301-310 of 338) with videos related to
Page
of 34
Sort By:
Aesthetic Plastic Surgery
|
April 6, 2021
How to Approach Secondary Breast Reduction: International Trends and a Systematic Review of the Literature
P Niclas Broer, Nicholas Moellhoff, Thiha Aung, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1996
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum
R G Ridley, W Hofheinz, H Matile, et al.
Frontiers in Medicine
|
April 29, 2021
Reprogramming Intestinal Epithelial Cell Polarity by Interleukin-22
Deborah Delbue, Lydia Lebenheim, Danielle Cardoso-Silva, et al.
Nature Biotechnology
|
May 21, 2020
Author Correction: Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Michelle F Richter, Kevin T Zhao, Elliot Eton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 3, 2014
A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation
Rose A Whelan, Sebastian Rausch, Friederike Ebner, et al.
Chemmedchem
|
December 11, 2012
2-Phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1 (TGR5)
Rainer E Martin, Caterina Bissantz, Olivier Gavelle, et al.
Science (New York, N.Y.)
|
February 13, 1970
Earthquakes and nuclear detonations
D L Anderson, C B Archambeau, J N Brune, et al.
Mabs
|
July 9, 2021
Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting
Thomas Kissner, Guenter Blaich, Andreas Baumann, et al.
Nature Biotechnology
|
May 21, 2020
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Michelle F Richter, Kevin T Zhao, Elliot Eton, et al.
Journal of Alzheimer'S Disease : JAD
|
September 30, 2011
Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β
Bernd Bohrmann, Karlheinz Baumann, Jörg Benz, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 338) with videos related to
Sort By:
Page
of 34
Aesthetic Plastic Surgery
|
April 6, 2021
How to Approach Secondary Breast Reduction: International Trends and a Systematic Review of the Literature
P Niclas Broer, Nicholas Moellhoff, Thiha Aung, et al.
Antimicrobial Agents and Chemotherapy
|
August 1, 1996
4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum
R G Ridley, W Hofheinz, H Matile, et al.
Frontiers in Medicine
|
April 29, 2021
Reprogramming Intestinal Epithelial Cell Polarity by Interleukin-22
Deborah Delbue, Lydia Lebenheim, Danielle Cardoso-Silva, et al.
Nature Biotechnology
|
May 21, 2020
Author Correction: Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Michelle F Richter, Kevin T Zhao, Elliot Eton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 3, 2014
A transgenic probiotic secreting a parasite immunomodulator for site-directed treatment of gut inflammation
Rose A Whelan, Sebastian Rausch, Friederike Ebner, et al.
Chemmedchem
|
December 11, 2012
2-Phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1 (TGR5)
Rainer E Martin, Caterina Bissantz, Olivier Gavelle, et al.
Science (New York, N.Y.)
|
February 13, 1970
Earthquakes and nuclear detonations
D L Anderson, C B Archambeau, J N Brune, et al.
Mabs
|
July 9, 2021
Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership Meeting
Thomas Kissner, Guenter Blaich, Andreas Baumann, et al.
Nature Biotechnology
|
May 21, 2020
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Michelle F Richter, Kevin T Zhao, Elliot Eton, et al.
Journal of Alzheimer'S Disease : JAD
|
September 30, 2011
Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β
Bernd Bohrmann, Karlheinz Baumann, Jörg Benz, et al.
Page
of 34